NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Manuel Comabella, Lukas Amman et al.|Brain|2020Cited by 136
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosisLaura Calvo‐Barreiro, Carmen Espejo, Herena Eixarch et al.|Autoimmunity Reviews|2017Cited by 95
Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune EncephalomyelitisLaura Calvo‐Barreiro, Carmen Espejo|Neurotherapeutics|2021Cited by 42